BigHat Biosciences
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
733 Industrial Rd, San Carlos, Californi...Website
www.bighatbio.comRevenue
$12.7 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
3
3
1
1
1
About BigHat Biosciences
BigHat Biosciences is reimagining antibody discovery and engineering with an AI-first experimental platform that integrates a high-speed wet lab with machine learning to create better antibodies faster and undertake novel designs far beyond what's possible today. BigHat applies these design capabilities to develop new generations of safer and more effective treatments for patients suffering from today's most challenging diseases. BigHat is a biotechnology company based in San Mateo, California with a team-oriented, inclusive, and family-friendly culture. BigHat is backed by a16z, 8VC, AME Cloud Ventures, and Innovation Endeavors and counts among its employees and advisors a Nobel Laureate, a serial life-science entrepreneur, and leaders in fields from antibody development to machine learning.Explore more
BigHat Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is BigHat Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on BigHat Biosciences recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at BigHat Biosciences
Check if BigHat Biosciences has recently received funding, and reach out quickly before it becomes old news!
Click to see if BigHat Biosciences had a recent Job posting/layoffs
Check out if BigHat Biosciences is spiking on competitors!
BigHat Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when BigHat Biosciences launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once BigHat Biosciences has new funding data
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined BigHat Biosciences as Masked Content
Find more new buyers
Compare Similar Companies to BigHat Biosciences
Compare insights from companies similar to BigHat Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
BigHat Biosciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
BigHat Biosciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about BigHat Biosciences.
BigHat Biosciences financials insights
Gather financial insights about BigHat Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Series A
$19M
2022
Series B
$75M
BigHat Biosciences Tech Stack
A closer look at the technologies used by BigHat Biosciences
See more technologies
Most Recent Scoops
Open Position
New Hire
Executive Move
Executive Moves, New Hire
Hiring Plans
BigHat Biosciences has more open roles in Engineering & Technical than it has had at any time in the past 6 months. Technologies mentioned include: Amazon AWS, Python, SQLAlchemy, and PyTorch.
Hiring Plans
Person-Based
Events
Open Position
BigHat Biosciences News & Media
Eli Lilly and BigHat Biosciences ink AI antibody discovery deal
The agreement adds to Eli Lilly’s growing portfolio of AI-enabled drug discovery partnerships.BigHat Biosciences and Lilly Collaborate to Advance AI-Driven Antibody Therapeutics
SAN MATEO, Calif.--(BUSINESS WIRE)--BigHat Biosciences (“BigHat”), a biotechnology company with a machine learning (ML)-guided antibody discovery and development platform, announced a strategic collaboration with Eli Lilly and Company (“Lilly”). In this collaboration, BigHat will deploy its Milliner platform, a suite of state-of-the-art ML technologies integrated with a synthetic biology-based high-speed wet lab, to design and engineer therapeutic antibodies with superior functionality. BigHatLonza's Synaffix Collaborates with BigHat Biosciences on the Development of a Machine Learning-Designed ADC
Commercial license to Synaffix technologies follows a series of successful initial preclinical proof of concept studies Collaboration underscores Lonza's commitment to helping customers deliver innovative new therapies to patients by offering a comprehensive service offering for...BigHat Biosciences Enters Into Strategic Collaboration to Leverage Machine Learning in Antibody Discovery & Design
SAN MATEO, Calif.--(BUSINESS WIRE)--BigHat Biosciences, a biotechnology company with an artificial intelligence/machine learning-guided antibody discovery and development platform announced a collaboration with Janssen Biotech Inc., a Johnson & Johnson company. This strategic collaboration combines the drug discovery, clinical development and data science expertise from Johnson & Johnson with BigHat’s Milliner™ platform, a suite of machine learning technologies integrated with a high-sp
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding BigHat Biosciences
Sign Up For FreeTo access detailed company insights
BigHat Biosciences is reimagining antibody discovery and engineering with an AI-first experimental platform that integrates a high-speed wet lab with machine learning to create better antibodies faster and undertake novel designs far beyond what's possible today. BigHat applies these design capabilities to develop new generations of safer and more... Read More
